Beijing Double-crane Pharmaceutical Acquires Shenzhou Pharmaceutical
This article was originally published in PharmAsia News
Executive Summary
Guangdong Shenzhou Pharmaceutical, one of the few companies producing soft packaging for transfusion in South China, faces huge debts after establishing four advanced production lines for PVC soft packaging. Beijing Double-crane Pharmaceutical will acquire 90 percent stake of the cash-strapped company for a token 1 yuan; the purchase will double its soft packaging production capacity and improve current processes and bottom line. The acquisition of high-tech hardware and manufacturing facilities will strengthen Double-crane's position in South China and improve its nationwide production network. Double-crane will incorporate Shenzhou's management, production, purchase and allocation processes into its management model for maximum optimization. (Click here for more - Chinese Language)
You may also be interested in...
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.